Next generation gene therapy vectors

Inspired By Nature – Motivated by Health

At Havedic Pharmaceutical we are driven by our curiosity and dedication. We want to help pave the way for Next generation of gene therapies. At Havedic we have the expertise and commitment to generate novel AAV capsids that can be used to tackle a wide array of disorders. Using state of the art methodologies within cloning, virus variant production and sequencing, we build novel viral vectors for precision targeting of defined cell populations or with desired properties.

What we offer

Unique approach

AAV Peptide display, combined with unique DNA barcoding and next generation sequencing allows for easy screening of AAV libraries containing millions of rationally designed, targeted AAV variants in a single screen.

Fast & Flexible

Choose your target, tissue type, cell population or application. Havedic designs a targeted, rationally designed AAV peptide display library which can be combined by a generated library of promotor & enhancer elements for increased cell and tissue specific expression.

Translational at scale

Havedic offers screening of the AAV peptide library in animal models ranging from rodents to non-human primates, ensuring that the delivered product translates within mammalian species and are prime candidates for clinical trials.

Advancing Gene Therapy Through Collaboration

At Havedic Pharmaceutical, we are proud to collaborate with industry leaders and innovators to advance the frontiers of gene therapy. Our partners are integral to our mission of developing cutting-edge solutions and driving impactful change in the field of adeno-associated virus (AAV) technologies.